1
|
Nennig K, Murthy S, Maloney S, Shaw TM, Sharobim M, Matkovic E, Fadiran S, Larsen M, Ramuta MD, Kim AS, Teijaro JR, Grove J, Stremlau M, Sharma H, Trivedi S, Blum MJ, O’Connor DH, Hyde JL, Stapleton JT, Kapoor A, Bailey AL. Determinants of pegivirus persistence, cross-species infection, and adaptation in the laboratory mouse. PLoS Pathog 2024; 20:e1012436. [PMID: 39196893 PMCID: PMC11355568 DOI: 10.1371/journal.ppat.1012436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Accepted: 07/22/2024] [Indexed: 08/30/2024] Open
Abstract
Viruses capable of causing persistent infection have developed sophisticated mechanisms for evading host immunity, and understanding these processes can reveal novel features of the host immune system. One such virus, human pegivirus (HPgV), infects ~15% of the global human population, but little is known about its biology beyond the fact that it does not cause overt disease. We passaged a pegivirus isolate of feral brown rats (RPgV) in immunodeficient laboratory mice to develop a mouse-adapted virus (maPgV) that established persistent high-titer infection in a majority of wild-type laboratory mice. maRPgV viremia was detected in the blood of mice for >300 days without apparent disease, closely recapitulating the hallmarks of HPgV infection in humans. We found a pro-viral role for type-I interferon in chronic infection; a lack of PD-1-mediated tolerance to PgV infection; and multiple mechanisms by which PgV immunity can be achieved by an immunocompetent host. These data indicate that the PgV immune evasion strategy has aspects that are both common and unique among persistent viral infections. The creation of maPgV represents the first PgV infection model in wild-type mice, thus opening the entire toolkit of the mouse host to enable further investigation of this persistent RNA virus infections.
Collapse
Affiliation(s)
- Kylie Nennig
- Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Satyapramod Murthy
- Center for Vaccines and Immunity, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, United States of America
| | - Sara Maloney
- Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Teressa M. Shaw
- Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Mark Sharobim
- Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Eduard Matkovic
- Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Simi Fadiran
- Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Malorie Larsen
- Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Mitchell D. Ramuta
- Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Arthur S. Kim
- Department of Immunology and Microbiology, The Scripps Research Institute, San Diego, California, United States of America
- Department of Chemistry, The Scripps Research Institute, San Diego, California, United States of America
| | - John R. Teijaro
- Department of Immunology and Microbiology, The Scripps Research Institute, San Diego, California, United States of America
| | - Joe Grove
- MRC-University of Glasgow Center for Virus Research, Glasgow, United Kingdom
| | - Matthew Stremlau
- Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
| | - Himanshu Sharma
- Center for Vaccines and Immunity, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, United States of America
| | - Sheetal Trivedi
- Center for Vaccines and Immunity, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, United States of America
| | - Michael J. Blum
- Department of Ecology & Evolutionary Biology, University of Tennessee, Knoxville, Tennessee, United States of America
| | - David H. O’Connor
- Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Jennifer L. Hyde
- Department of Microbiology, University of Washington, Seattle, Washington, United States of America
| | - Jack T. Stapleton
- Department of Internal Medicine, Microbiology & Immunology, University of Iowa and Iowa City Veterans Affairs Healthcare System, Iowa City, Iowa, United States of America
| | - Amit Kapoor
- Center for Vaccines and Immunity, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio, United States of America
- Department of Pediatrics, College of Medicine and Public Health, Ohio State University, Columbus, Ohio, United States of America
| | - Adam L. Bailey
- Department of Pathology and Laboratory Medicine, University of Wisconsin–Madison School of Medicine and Public Health, Madison, Wisconsin, United States of America
| |
Collapse
|